International Biotechnology Trust PLC Blueprint Medicines Corp Transaction History
International Biotechnology Trust PLC
- $295 Million
- Q3 2023
A detailed history of International Biotechnology Trust PLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, International Biotechnology Trust PLC holds 20,000 shares of BPMC stock, worth $2.24 Million. This represents 0.34% of its overall portfolio holdings.
Number of Shares
20,000Holding current value
$2.24 Million% of portfolio
0.34%Shares
5 transactions
Others Institutions Holding BPMC
# of Institutions
350Shares Held
60.3MCall Options Held
2.25MPut Options Held
1.18M-
Vanguard Group Inc Valley Forge, PA6.68MShares$748 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$744 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.39MShares$603 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA3.96MShares$444 Million0.07% of portfolio
-
State Street Corp Boston, MA2.77MShares$310 Million0.01% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $6.69B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...